FR 190997

Drug Profile

FR 190997

Latest Information Update: 18 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fujisawa
  • Developer Fujisawa; Nonindustrial source
  • Class
  • Mechanism of Action Bradykinin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Hypertension; Myocardial infarction

Most Recent Events

  • 16 Mar 2000 FR 190997 is being investigated for use in hypertension
  • 16 Mar 2000 Preclinical development for Hypertension in Japan (Unknown route)
  • 27 Sep 1999 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top